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Unsafe injections and the transmission of
hepatitis B and C in a periurban community
in Pakistan
Aamir J. Khan,1 Stephen P. Luby,2 Fariyal Fikree,2 Anita Karim,3 Saima Obaid,3 Salima Dellawala,3
Shaper Mirza,4 Tariq Malik,4 Sue Fisher-Hoch,5 & Joseph B. McCormick6
Following reports of frequent deaths associated with jaundice and chronic liver disease among adults in a periurban
community of Karachi, Pakistan, an investigation was conducted to evaluate the relationship between injections and
viral hepatitis infections, to identify the reasons why patients received frequent injections, and to observe the injection
practices employed in clinics. Two hundred and three adult patients were interviewed as they left each of the 18 area
clinics. Practitioners were interviewed and three consecutive injections were observed at each clinic. Eighty-one per
cent of patients received an injection on the day of the interview. Of the 135 patients who provided a serum sample,
59 (44%) had antibodies against hepatitis C virus and 26 (19%) had antibodies against hepatitis B virus. Patients who
received more injections were more likely to be infected with hepatitis C. If oral and injected medications were equally
effective, 44% of patients preferred injected medication. None of the practitioners knew that hepatitis C could be
transmitted by injections. Non-sterile syringes and needles that had been used earlier in the day on other patients were
used for 94% of the observed injections. Interventions to limit injections to those which are safe and clinically
indicated are needed to prevent injection-associated infections in Pakistan and other low-income countries.
Keywords: hepatitis B, transmission; hepatitis C, transmission; injections, adverse effects; epidemiological studies;
Pakistan.
Voir page 962 le re´sume´ en franc¸ais. En la pa´gina 962 figura un resumen en espan˜ol.
Introduction
Hepatitis C virus (HCV) is a bloodborne pathogen
responsible for a substantial proportion of cases of
post-transfusion hepatitis, liver cirrhosis and hepato-
cellular carcinoma (1, 2). The most commonly
identified routes of HCV transmission in developed
countries include intravenous drug use, blood
transfusions, haemodialysis, needle-stick injuries
among health professionals, tattooing, sexual inter-
course and perinatal infections (3–8). In developing
countries, the reuse of needles and syringes without
sterilization for therapeutic injections has been
implicated as a vehicle for transmission of blood-
borne organisms including hepatitis B virus (HBV),
human immunodeficiency virus (HIV), Ebola virus,
Lassa fever virus, and HCV (9–15).
In1993acommunity-based survey inHafizabad,
Pakistan, found the prevalence of antibody against
HCV to be 6.5%, and a follow-up case-control study
showed that patients infected with HCV were seven
times more likely than controls to report averaging
ten or more therapeutic injections per year in the
previous ten years (13). The study design did not
permit assessment of the practices of health care
providers or their perceptions regarding the potential
risks of needle reuse.
In 1995 we received reports of increasingly
frequent deaths of adults which were associated with
jaundice and chronic liver disease in Darsano Channo,
a periurban agricultural community of Karachi over
1100 kilometres from Hafizabad. These reports led us
to conduct an investigation into the relationship
between hepatitis infections and injections, the
reasons why patients received frequent injections,
and the injection practices employed in clinics.
Methods
Setting
Darsano Channo is a periurban subdistrict 20 kilo-
metres north-east of Karachi, comprising nearly
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30 village centres with, according to the most reliable
estimate available, approximately 13 000 people of
Sindhi and Balochi descent. The primary source of
income formost families is agricultural labour on land
owned by a small number of landowners; a small
proportion of educated men are employed by the
government in local service or in Karachi. The adult
population is largely unable to read or write.
Design
On five days in January 1995 a group of final-year
medical students from the Aga Khan University
approached consecutive patients as they left 18 health
clinics in Darsano Channo. If the patients consented
and were at least 20 years of age the students
administered a structured questionnaire on present-
ing health complaints, injections given on the day and
previously, and attitudes towards injections. A blood
specimen was collected from each patient who gave
informed consent. Patients aged 20 or more were
enrolled to provide sufficient data for statistical
analysis, a previous study in Pakistan having demon-
strated that HCV infection increased markedly with
age (13).
The study team asked the health care
providers at the clinics about their qualifications,
work experience, patient turnover and injecting
practices. A questionnaire asked the practitioners to
state the common medical indications for which
they prescribed injections, the types of injectable
drugs prescribed, why they preferred injectable
drugs over oral forms and the diseases likely to be
transmitted through the reuse of non-sterile needles.
A structured form was used to record observations
made on three consecutive patients who received
injections in each clinic. This number was chosen
because of the limited time and numbers of
observers, the desire to make observations in all
the clinics, and the expectation that three observa-
tions per practitioner would give an adequate picture
of routine practice.
Three periods of patient exposure to thera-
peutic injections were considered: the 12 months
preceding the study, i.e. 1994; 1989 to 1993; and, for
persons aged 30 or more, 1978 to 1988. Respondents
were asked to report their average number of yearly
injections in the following categories: zero, 1–4, 5–10
and more than ten.
Laboratory procedures
Serum was separated and stored at –70 oC at the
laboratory of the Aga Khan University Hospital.
HCV infection was defined as the presence of serum
HCV antibodies detected by a third-generation
enzyme-linked immunosorbent assay (Abbott EIA).
Because the prevalence ofHCV infection in the study
population was much higher than expected we
selected a random sample of ten HCV antibody-
positive aliquots and repeated the HCV antibody test
from a different batch of kits. We also tested the
serum for antibodies against HBV core antigen (anti-
HBc, Abbott EIA). We interpreted the presence of
anti-HBc as evidence of past HBV infection.
Statistics
Interview forms were coded and double-entered into
Epi Info software (16).We compared the prevalences
of infection between groups on the basis of
prevalence ratios and used the w2-test and Yate’s
corrected P-values to evaluate statistical significance,
with Taylor Series 95% confidence limits. The w2-test
for linear trend was employed to evaluate the
relationship between current infection and number
of injections over time.
Results
Patients
We interviewed 203 patients aged at least 20 years as
they left the clinics. Their mean age was 36 years
(range 20–80); there were 127 females (63%) and
76 males (37%). The mean ages for females and
males were 35 and 37 years respectively. Seventy-six
per cent of the females were housewives and 55% of
themaleswere involved in agricultural labour; 75%of
the females and 54%of themales were unable to read
or write.
One hundred and thirty-five patients (67%)
agreed to provide a serum sample. The sex
distribution (63% male versus 62% female) and
mean age (38 versus 35 years) of thosewho refused to
give a blood sample and those who agreed were
similar. Of the females and males who did not
provide a serum sample, 90% and 69% respectively
could not read or write.
Of the 135 serum samples procured and tested,
59 (44%) had antibodies against HCV and 26 (19%)
had antibodies against HBV core antigen. Forty-three
of 85 females (51%) and 16 of 50 males (32%) were
infected with HCV (prevalence ratio = 1.6, P = 0.05).
Compared to patients aged 20–24 years, all older age
groups were 4 to 6 times more likely to be infected
with HCV. The prevalence of anti-HBc antibodies did
not differ significantly by sex or age group (Table 1).
The primary symptoms prompting these
patients to visit the clinic included generalized
muscular and joint aches (22%), abdominal discom-
fort (20%), acute febrile illness (18%) and respiratory
tract infections (13%). An injection was received
during the visit to the clinic by 165 patients (81%),
including 90% of those aged 20–24 years. Seventy-
three per cent of patients did not know whether the
needle and syringe used to inject them were sterile;
17% reported them to be reused and 10% observed a
new syringe being drawn from its packet.
Among all 203 exit patients, the percentage
who reported averaging more than ten injections per
year increased from 52% in 1978–88 to 69% during
1989–93 and to 73% during 1994. Those averaging
zero injections per year decreased from 34% during
1978–88 to 16% during 1989–93 and to 5% during
1994.
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Women were twice as likely as men to report
receiving over ten injections per year during 1994
(prevalence ratio = 1.9, 95% confidence interval (CI)
1.2–3.0, P < 0.01). In comparison to men in
corresponding age groups, women aged 30–39 years
were twice as likely to report receiving more than ten
injections per year during 1994 (prevalence ratio 2.1,
95% CI 1.2–3.9, P < 0.02), and women aged 25–29
years of age were five times more likely than similarly
aged men to report receiving over ten injections per
year during the same year (prevalence ratio = 5.0,
95% CI 1.2–20.3, P < 0.02). Such increased ex-
posure for women was not statistically evident prior
to 1994.
Among the 135 patients for whom serology
results were available, those who received more
injections during 1994 and during 1989–93 were
significantly more likely to be infected with HCV
(Table 2). Antibody to HBV core antigen was not
associated with the average number of injections
received during the same time periods.
Fifteen per cent of patients reported that they
had previously received a blood transfusion, and
these patients were 1.9 times more likely to be
infected with HCV. However, this and other
associations between parenteral exposures and
HCV and HBV infection were not statistically
significant (Table 3).
If oral and injectable medicines were equally
effective in the treatment of a given illness, 90 of the
patients (44%) said they would prefer an injectable.
Twenty-nine (14%) said they always insisted on
receiving injectable drugs when they visited health
care practitioners; 41 (20%) said they did so usually or
occasionally. Forty-one per cent of the patients
thought that oral medication was more expensive
than injectable medication. Only 48 patients (24%)
reported ever having asked their practitioner for oral
medication in preference to an injectable drug that
had been prescribed.
Health care providers
We interviewed 18 health care providers during
working hours in the clinics, which contained one to
three rooms and lacked laboratory and radiology
facilities. Ten of the providers were registered
medical practitioners; the sole qualification of the
others was previous apprenticeship under such
practitioners. The registered practitioners reported
an average of 60 patient visits a day; the unregistered
practitioners reported 25 such visits. The mean
duration of practice as an independent health care
provider was 13 years.
Eight of the ten registered practitioners and six
of the eight unregistered practitioners said that life-
threatening diseases could be spread through the reuse
of non-sterile needles and syringes. When asked to
mention diseases likely to be transmitted in this
manner, none of the practitioners referred to HCV;
only two mentioned HBV, and over half mentioned
tuberculosis (Table 4). When asked to estimate the
percentage of their patients seen on a working day for
whom they prescribed an injectable drug, the
responses ranged from 60% to 75%. The most
common diseases reported for which these injectable
drugs were administered included respiratory tract
infections (9; 50%), malaria (8; 44%), gastroenteritis
(8; 44%) and generalized weakness (4; 22%). Accord-
ing to the practitioners, their reasons for preferring
injectable drugs over oral counterparts included the
Table 1. Prevalence of antibodies to hepatitis C and hepatitis B core antigen by age group and gender
in 135 patients leaving clinics in Darsano Channo, 1995
Positive for HCV antibody Positive for anti-HBV core antigen
n (%) n (%)
Age group Females Males Total Prevalence Females Males Total Prevalence
(years) % ratio across % ratio across
age groupsa age groupsa
20–24 3/18 0/10 3/28 Baseline 3/18 3/10 6/22 Baseline
(17) (11) (17) (30) (21)
25–29 7/12 7/14 14/26 5 2/12 1/14 3/23 0.5
(58) (50) (54) (1.60–15.5) (17) (7) (11) (0.1–1.7)
30–34 10/14 2/7 12/21 5.3 4/10 3/7 7/21 1.2
(71) (29) (57) (1.7–16.5) (29) (43) (33) (0.5–3)
35–39 6/11 3/10 9/21 4 2/11 1/10 3/21 0.5
(54) (30) (43) (1.2–13) (18) (10) (14) (0.1–1.8)
40–49 9/13 0/1 9/14 6 1/13 0/1 1/14 0.3
(69) (64) (1.9–18.7) (8) (0.04–1.9)
5 50 8/17 4/8 12/25 4.5 4/17 2/8 6/25 0.9
(47) (50) (48) (1.4–14.1) (24) (25) (24) (0.3–2.3)
All age 43/85 16/50 59/135 NAb 16/85 10/50 26/135 NAb
groups (51) (32) (44) (19) (20) (19)
a Prevalence ratio across age groups using the 20–24 years age group as the baseline. Values in parentheses are Taylor Series 95%
confidence intervals for prevalence ratios.
b Not applicable.
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quick relief of symptoms (15; 83%), greater effective-
ness (7; 39%), lower frequency of side-effects (6; 33%)
and patient satisfaction (4; 22%).
Practitioners prescribed a wide range of
injectable therapeutic agents including mixtures of
two or more drugs. All 18 practitioners reported
prescribing injectable antibiotics, most commonly
gentamicin, penicillin G and cephalosporins for a
broad range of suspected infectious diseases. Seven
practitioners (39%) reported prescribing injectable
chloroquine for suspected malaria. Seven (39%) also
used mixtures of vitamins with analgesics adminis-
tered intramuscularly for complaints of generalized
weakness and muscular or joint aches.
Observations in clinics
The use of a new needle was observed on two
occasions and the opening of a packet containing a
syringe with a needle was seen on one occasion
during observations on the administration of 54 in-
jections. For the other 51 injections both the needle
and the plastic disposable syringe had been used on
another patient during the same working day. In all
clinics, needles were observed either in a pan of tepid
water or lying open on a table. Between uses, syringes
were always placed on a table.
Discussion
Forty-four per cent of patients aged at least 20 years
who visited health clinics in a periurban setting
outside Karachi were infected with HCV. The
primary route of transmission was evidently injection
with reused, inadequately sterilized needles and
syringes. There was a strong dose-dependent
association between the numbers of injections
received and HCV infection during two periods of
exposure: the 12 months prior to interview and the
five years preceding them. It is possible that persons
with HCV were symptomatic and thus more likely to
come to practitioners and receive injections, with the
consequence that HCV infection was the reason for
the injections rather than vice versa. However, if the
injections were not responsible for HCV infection
there would need to be another cause of the 44%
prevalence of HCV in the population. Other
parenteral risk factors were evaluated, but none were
significantly associated withHCV. If the cause of this
high prevalence was an unknown risk factor not
covered in the questionnaire, the observation that
94% of injections were administered with unster-
ilized reused syringes and needles would be an
irrelevant finding. This, given the limitations of a
cross-sectional study, is arguable, but the more
straightforward explanation that injections led to
HCV infection is more plausible. Moreover, this
relationship between unsafe injections and HCV
infection has been observed elsewhere in Pakistan
(13) and in Taiwan, China (14, 15). It is consistent
with the associations observed between HCV
transmission and injecting drug use (2) and needle-
stick injuries (5).
These data also suggest that most transmission
of HCV in Darsano Channo occurred within the five
years preceding the investigation. The strongest
association was between HCV infection and the
receipt of injections in the previous year; a weaker
association occurred in respect of the preceding 2–
6 years, and there was no association with injections
given more than 6 years previously. Furthermore,
Table 2. Association between anti-HCV reactivity and average
number of injections received in 1994, 1989–93 and 1978–88,
Darsano Channoa
No. positive No. negative HCV
for HCV for HCV odds ratio
antibody antibody
Average number of injections
in the last year
0 1 6 1.0 (baseline)
1–4 2 9 1.3
5–9 5 14 2.2
510 51 47 6.5
w2 for linear trend, P = 0.002
Average number of injections
per year, 1989–93
0 6 15 1.0 (baseline)
1–4 1 4 0.63
5–9 5 9 1.4
510 47 48 2.4
w2 for linear trend, P = 0.048
Average number of injections
per year, 1978–88
0 17 29 1.0 (baseline)
1–4 2 3 1.1
5–9 4 6 1.1
510 36 38 1.6
w2 for linear trend, P = 0.21
a Persons who responded ‘‘don’t know’’ when questioned as to the average number of
injections for a particular time frame were excluded from the analysis.
Table 3. Lack of association between HCV and HBV infection
with other potential routes of transmission, Darsano Channo, 1995
Other risk factors Total No. positive HCV No. positive
n (%) for HCV prevalence for HBV
antibodya ratiob core antigen
antibodya
Receiving blood 31/203 (15) 12/22 (55) 1.9 4/22 (18)
transfusion (0.7–5.4)
Injecting drug use 8/203 (4) 2/7 (28) 0.5 2/7 (28)
(0.1–3.1)
Extramarital sexual 26/203 (13) 7/19 (37) 0.7 5/19 (26)
intercourse (0.2–2.2)
a No. positive among those who provided serum samples. Values in parentheses are
percentages.
b Values in parentheses are Taylor Series 95% confidence intervals for prevalence ratio.
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persons aged at least 25 were at markedly greater risk
of HCV infection than persons aged 20–24 years, but
above the age of 30 there was no increased risk relative
to the already elevated risk of persons aged 25–
29 years. If the rate of infection were steady and long-
standing, increased infection in each age group would
be expected. Thus, although injections were com-
monly used in the 16 years prior to the study (1978–
94), the virus was apparently either introduced or
reached sufficient prevalence for exponential spread
within the population during the five years preceding
the investigation. This is consistent with a study in a
village in Taiwan, China, suggesting that most
community-wide HCV transmission from injections
occurred during distinct time frames (14).
This model of widespread risk behaviour but
episodic large-scale transmission is consistent with
the varying prevalence of HCV reported in different
communities. Two epidemics of HCV caused by
injections from inadequately sterilized needles have
been documented in Pakistan, one in the present
study and the other in Hafizabad (13), a community
with a different language and culture and separated
fromDarsanoChanno by over 1100 kilometres. Both
communities were investigated following reports of
liver disease. Although injections are widely popular
in Pakistan (17), rates ofHCV infection are below 2%
in other communities, including voluntary blood
donors in Karachi (18) and residents in four squatter
settlements in Karachi (S. Thobani, personal com-
munication). Patchy outbreaks of HCV against a
background of widespread unsafe injections suggest
that interventions to improve needle hygiene could
prevent an exponential increase in transmission in the
many communities where HCV prevalence and
injection behaviour resembled the conditions in
DarsanoChanno in the ten years preceding our study.
However, it is not easy to bring about a
reduction in unsafe and unnecessary injections.
Patients in Darsano Channo actively sought injec-
tions. Seventy-three per cent of the patients had
received more than ten injections in the preceding
year, and 44% preferred injections to oral medica-
tions even where they were equally effective.
Practitioners, unaware of many of the specific risks
of bloodborne pathogen transmission through injec-
tions, were providing a service that peoplewanted at a
modest price. Complete medical evaluation was not a
part of this study; nevertheless, the fact that 81% of
the patients visiting primary care clinics received a
parenteral injection in the absence of laboratory or
radiological evaluation pointed to unnecessary par-
enteral therapy.
The consequences of frequent unsafe injec-
tions were not borne equally within the community.
Over half of all the women were infected with HCV.
Women sought more care at these clinics, received
more injections and were twice as likely as men to be
infected with HCV. This increased exposure to
injections was particularly evident in women aged
30–39 years, the peak reproductive age range of
women in Pakistan. In Darsano Channo, women’s
social roles and mobility are strictly prescribed.
Somatization, the expression of psychological stress
as physical symptoms, is responsible globally for a
large percentage of visits to health care providers (19)
and is likely to account for many visits to clinics in
Darsano Channo. When Darsano Channo residents
felt unwell they sought injections.
Although hepatitis B virus can be transmitted
by reused injection equipment the present study did
not find an association between hepatitis B and
injections. There are two likely reasons for this. First,
85%of the persons who have anti-HCV antibodies as
detected by second-generation enzyme-linked im-
munosorbent assay have circulating HCV virus and
so can readily transmit the infection (20). In contrast,
in a previous study in Pakistan, only 14% of persons
with antibodies to hepatitis B core antigen had
evidence of infectivity, i.e. circulating hepatitis B
surface antigen (13). In Darsano Channo, therefore,
the opportunities for HCV transmission via con-
taminated injection equipment were more frequent
than for HBV transmission. Second, hepatitis B is
more efficiently transmitted vertically and sexually
than hepatitis C (21, 22). In this relatively small study,
substantial HBV transmission that was not associated
with injection could have obscured an association
between injections and HBV infection.
It is worth noting the following limitations of
the present study.
. Exposure to injections was assessed by ques-
tionnaire. Recall, especially over long time frames,
is imperfect. However, patients were unaware of
their HCV status when they were questioned, so
imperfect recall would lead to non-differential
misclassification of exposure which would bias
associations to the null. Thus, while there may be
additional associations between exposures and
outcomes which the study failed to recognize,
those that it did identify are probably valid.
. Because this was a cross-sectional study it was
impossible to distinguish completely howmuch of
Table 4. Perceptions of health care providers as to diseases likely
to be transmitted because of reuse of non-sterile needles
for injections, Darsano Channo, 1995
What diseases are likely to be transmitted
because of reuse of non-sterile needles (n = 18)?
Disease Registered Unregistered
practitionersa (n = 10) practitionersb (n = 8)
AIDS 8 (80) 4 (50)
Hepatitis B 2 (20) 0 (0)
Hepatitis C 0 (0) 0 (0)
Malaria 5 (50) 5 (62)
Tuberculosis 5 (50) 5 (62)
Typhoid fever 5 (50) 5 (62)
Cancer 0 (0) 2 (25)
a Qualified medical graduates registered with the Pakistan Medical and Dental Council.
Values in parentheses are percentages.
b Health care providers who were not medical school graduates and were not registered
with the Pakistan Medical and Dental Council. Values in parentheses are percentages.
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the varying prevalence of HCV with age was a
result of an age effect, a period effect, or a cohort
effect. However, in contrast to other populations
with HCV which showed a steady increase in
HCV prevalence with age (13, 23, 24), the
prevalence in Darsano Channo peaked at 25–
29 years of age, indicating more than a simple age
effect. Whether this unusual age distribution of
infection was something that happened during a
particular period, resulting in increased prevalence
for all age groups, or whether persons in a specific
birth cohort were susceptible to unique conditions
of their birth cohort, cannot be resolved com-
pletely with cross-sectional data. Nevertheless, the
retrospective data on exposure to injections
identifies a particular period, i.e. the year prior to
the study, as the time of strongest association with
infection. This contrasts with the results from
Hafizabad: injections in the preceding year were
not associated with HCV infection, whereas there
was an association between injections in the
preceding five and ten years and HCV infection
(13). Moreover, whether the responsible event
occurred among all ages, i.e. a period effect, or
among a particular age group, i.e. a cohort effect, it
appears that at some time in the recent past HCV
was widely transmitted through this community.
. The study raised substantial ethical conflicts. At the
outset the members of the team realized that they
would probably observe clinical practices that could
potentially transmit bloodborne infection, and
careful consideration was therefore given to the
acceptability of observation without immediate
intervention. Because the project was of short
duration, and because the Human Subjects Com-
mittee of the Aga Khan University met only
quarterly, formal external ethical review was
unavailable. It was decided to proceed for three
reasons.Firstly, to insiston interveningat the timeof
observation would undercut both the project and
effectivepublichealth intervention.Wewere invited
into clinics where both clinicians and patients
preferred injections. Hadwe violated the autonomy
of thecareproviders and thepatients and insistedon
an immediate change in practice, wewould not have
been allowed to continue observing and the care
providerswouldhavebeenunwilling tocooperate in
any follow-up activity aimed at reducing unsafe
injections. Stopping the process at the time of initial
observation would also have undercut the develop-
mentofbroader regionalpublichealth interventions
thatcouldonlyberationallybased if theproblemwas
realistically understood.Secondly, giving threeclean
needles andsyringes toeachcareprovideron theday
of observation would not have meaningfully
lessened the risk of bloodborne infection in a
populationwhereover three-quartersof thepatients
were receiving more than ten injections a year and
the reuse of injection equipment was usual. Thirdly,
had a different topic been chosen for study, a
possibility thatwas considered, the end resultwould
have been less controversy, the same number of
unsafe injections administered on the days of
planned observations, and no data to give back to
the community or to examine on a national or
international level. Althoughwedid not intervene at
the time of observation we did in fact plan and
intervene. Once the data were analysedwe returned
toDarsano Channo, divulged the laboratory results
and provided counselling and referral to the
participants in the study. We also shared the results
of the studywith the larger community, andwith the
local health care providers, and with other health
care providers and communities throughout the
region. We shared the data with colleagues in the
Sindh Government AIDS Prevention Programme,
who subsequently included the avoidance of unsafe
injections among the public health messages issued
via the mass media throughout the province of
Sindh,which has a population of 40million.We also
collaborated with a nongovernmental organization
in including thereductionofunnecessaryandunsafe
injections in an intervention programme for
improving clinical care in the area.
In developing countries, frequent injections are part
of a mutually re-enforcing cycle. Injections are
psychologically rewarding to patients, bring status
and financial reward to the injector, and occasionally
bring genuine health benefits (25). Consequently,
interventions should be addressed at the societal,
practitioner and patient levels. An important long-
term goal is to prevent unnecessary injections.
Research in developing countries which aimed at
measuring the average percentage of adult out-
patients in primary care settings who required
parenteral therapy would permit the establishment
of an evidence-based standard. Governments, non-
governmental organizations and communities could
use such a standard to evaluate local practices and
persuade practitioners and community members to
make the necessary modifications.
Efforts are needed to ensure that all injections
are administered with sterile syringes and needles.
The incremental cost to practitioners of using new
syringes or to community members of providing
their own syringes is small compared to the cost of
visits. A typical clinic visit in Karachi costs US$ 0.96,
while a sterile needle and syringe cost $0.06
(G. Raglow, personal communication). It is more
realistic to use cleaner injecting equipment in the
short term than to expect rapid change in the
psychological and economic dynamic that drives
unnecessary injections. Even in Hafizabad, where a
community-wide HCV outbreak caused by unsafe
injections was followed by an intensive two-year
information and education campaign, the average
number of injections per year among residents
remained unchanged, although the majority of
residents had started providing their own new syringe
and needle each time they visited a clinic (Fauzia
Hoodbhouy, personal communication).
As there is no immediate prospect of a vaccine
against HCV it is vital to combat unsafe injection
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practices in developing countries. This would not
only help to diminish the morbidity and mortality
associated with HCV but could also be expected to
prevent disease from needle-transmitted hepatitis B
virus, HIV and other bloodborne pathogens. n
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Re´sume´
Injections a` risque et transmission des he´patites B et C dans une communaute´
pe´riurbaine du Pakistan
Une e´tude ante´rieure, a` Hafizabad (Pakistan), avait e´tabli
une forte pre´valence des anticorps contre l’he´patite C en
relation avec des traitements par voie parente´rale. A la
suite de rapports faisant e´tat de de´ce`s fre´quents chez les
adultes, associe´s a` des icte`res et a` des affections
he´patiques chroniques dans une communaute´ pe´ri-
urbaine de Karachi, une enqueˆte a e´te´ mene´e sur le lien
entre les he´patites et les injections, les raisons de leur
fre´quence d’administration aux patients et la manie`re de
les pratiquer. A la sortie de 18 dispensaires, 203 patients
aˆge´s d’au moins 20 ans ont e´te´ interroge´s ; des
e´chantillons se´riques ont aussi e´te´ pre´leve´s lorsque les
sujets e´taient consentants. Les praticiens ont e´galement
e´te´ interroge´s et l’on a observe´, dans chaque dispensaire,
comment trois injections conse´cutives e´taient effectue´es.
On a obtenu 135 e´chantillons de se´rum (67 % des
patients) ; 59 (44 %) pre´sentaient des anticorps dirige´s
contre le virus de l’he´patite C et 26 (19 %) contre
l’antige`ne capsidique du virus de l’he´patite B. On a
associe´ l’he´patite C a` une exposition croissante aux
injections en 1994 (rapport de pre´valences = 6,5 ; w2
pour la tendance line´aire p = 0,002) par rapport a` 1989-
1993 (rapport de pre´valences = 2,4 ; w2 pour la tendance
line´aire p = 0,048). Quarante-trois des 85 femmes
(51 %) et 16 des 50 hommes (32 %) e´taient infecte´s par
le VHC (rapport de pre´valences = 1,6 ; p = 0,05). Au
cours des consultations, 165 patients (81 %) ont e´te´
traite´s par voie injectable et 73 % ont signale´ avoir rec¸u
plus de 10 injections au cours de l’anne´e pre´ce´dant la
consultation. La probabilite´ de signaler plus de
10 injections en 1994 e´tait deux fois plus grande pour
les femmes que pour les hommes. A efficacite´ e´gale des
me´dicaments par voie orale et par voie parente´rale, 44 %
des patients pre´fe´raient la seconde. Sur les 18 agents de
sante´ interroge´s, 10 e´taient des me´decins inscrits. Aucun
praticien ne savait que les injections pouvaient trans-
mettre l’he´patite C. Dans 94 % des injections observe´es,
les seringues et les aiguilles avaient de´ja` servi et
n’avaient pas e´te´ ste´rilise´es de nouveau. D’apre`s les
donne´es, on peut de´duire que la transmission parente´-
rale du VHC chez un praticien s’est produite dans la
plupart des cas au cours des cinq anne´es pre´ce´dant
l’enqueˆte. Ce type de comportement a` risque et de
transmission e´pisodique a` grande e´chelle correspond a` la
pre´valence variable du VHC dans les diverses commu-
naute´s et permet de penser qu’en intervenant pour
ame´liorer les conditions d’hygie`ne au moment des
injections, on pourrait e´viter une augmentation expo-
nentielle de la transmission dans de nombreuses
communaute´s. Il est difficile de diminuer le nombre
d’injections superflues : les patients recherchent ce mode
de traitement et les praticiens, observant peu de risques a`
court terme, acceptent volontiers de re´pondre a` leur
demande. Des interventions imme´diates, incitant a`
l’utilisation de mate´riel ste´rile, et des actions a` long
terme, pour limiter l’administration des injections aux cas
ou` elles sont me´dicalement justifie´es, sont ne´cessaires
pour pre´venir la transmission de l’he´patite C et d’autres
infections par voie parente´rale.
Resumen
Inyecciones peligrosas y transmisio´n de las hepatitis B y C en una comunidad periurbana
del Pakista´n
En un estudio anterior realizado en Hafizabad (Pakista´n)
se habı´a hallado una alta prevalencia de anticuerpos anti-
hepatitis C asociada a la administracio´n de inyecciones
terape´uticas. Tras recibir frecuentes notificaciones de
defunciones de adultos asociadas a ictericia y hepatopatı´a
cro´nica en una comunidad periurbana de Karachi, se llevo´
a cabo una investigacio´n sobre la relacio´n entre las
hepatitis y la administracio´n de inyecciones, sobre las
razones de que los pacientes recibieran tantas inyecciones
y sobre la naturaleza de las pra´cticas de inyeccio´n. Se
entrevisto´ a 203 pacientes de al menos 20 an˜os de edad a
su salida de 18 dispensarios, obtenie´ndose muestras de
suero de los pacientes que accedieron a ello. Se entrevisto´
a los me´dicos y se observo´ la manera de administrar las
inyecciones en tres ocasiones consecutivas en cada
dispensario. Proporcionaron muestras de suero 135 pa-
cientes (67%); 59 (44%) presentaban anticuerpos contra
el virus de la hepatitis C, y 26 (19%) tenı´an anticuerpos
contra el antı´geno nuclear del virus de la hepatitis B. La
infeccio´n por el virus de la hepatitis C se asocio´ a un
aumento de la exposicio´n a inyecciones durante 1994
(razo´n de prevalencia = 6 ,5; w2 para la tendencia lineal,
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P = 0,002) y entre 1989 y 1993 (razo´n de prevalencia =
2,4; w2 para la tendencia lineal, P = 0,048). Cuarenta y
tres de 85 mujeres (51%) y 16 de 50 hombres (32%)
estaban infectados por el VHC (razo´n de prevalencia =
1,6, P = 0,05). En sus visitas a los consultorios,
165 pacientes (81%) recibieron una inyeccio´n; el 73%
declararon que habı´an recibido ma´s de diez inyecciones
durante el an˜o previo a sus visita. En comparacio´n con los
hombres, las mujeres presentaban una probabilidad doble
de haber recibido ma´s de diez inyecciones durante 1994.
Aunque los medicamentos orales y los inyectables fueran
igualmente eficaces, un 44% de los pacientes preferı´an las
inyecciones. Diez de los 18 dispensadores de asistencia
sanitaria entrevistados eran me´dicos colegiados. Ninguno
de los profesionales sabı´a que la hepatitis C se puede
transmitir a trave´s de las inyecciones. En el 94% de las
inyecciones observadas se emplearon jeringas y agujas ya
utilizadas que no habı´an sido esterilizadas. Los datos
parecen indicar que la mayorı´a de los casos de transmisio´n
del VHC se produjeron a trave´s de inyecciones practicadas
por personal sanitario durante los cinco an˜os previos a la
investigacio´n. Este modelo de comportamiento de riesgo
generalizado y transmisio´n episo´dica en gran escala era
coherente con la distinta prevalencia del VHC observada
en diferentes comunidades y lleva a pensar que las
intervenciones encaminadas a mejorar la higiene de las
agujas podrı´an impedir que la transmisio´n aumentara
exponencialmente en muchas comunidades. Es difı´cil
reducir el nu´mero de inyecciones innecesarias, pues los
pacientes desean que les administren inyecciones, y los
profesionales, considerando que sus riesgos a corto plazo
son pocos, esta´n dispuestos a prestar el servicio que las
personas les piden. La prevencio´n de la hepatitis C y de
otras infecciones transmitidas por las inyecciones exige
intervenciones inmediatas de fomento del uso de equipo
de inyeccio´n este´ril, e intervenciones a ma´s largo plazo
encaminadas a asegurar que so´lo se administren las
inyecciones que este´n indicadas me´dicamente.
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